Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects

Trial Profile

Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Oct 2017

At a glance

  • Drugs Raxatrigine (Primary)
  • Indications Neuropathic pain; Trigeminal neuralgia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Convergence Pharmaceuticals
  • Most Recent Events

    • 04 May 2017 Status changed from active, no longer recruiting to completed.
    • 18 Sep 2015 New trial record
    • 24 Apr 2015 This trial was planned by Convergence. The Company has now been acquired by Biogen, according to Biogen media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top